U.S. District Judge Ann Donnelly of the Eastern District of New York denied requests to lift or modify asset freezes against the defendants in a lawsuit regarding alleged counterfeit HIV drugs, instead ordering that the asset freezes be entered as preliminary injunctions.
Donnelly on Monday ruled that the plaintiff, Gilead Sciences, met its burden to show that defendant Scripts Wholesale “engaged in a pattern of fraudulent or evasive conduct so as to justify a preliminary injunction freezing assets to satisfy a potential equitable award.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
